BLOG
Blog
Will Biosimilars Replace Biologics?
What are biosimilars, and what does the future hold in store for them?
Blog
What Effect Will the New NIH Policy Have On Multi-Site Research?
In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a single i...
Blog
What Does it Take? | Biologic and Biosimilar Clinical Trials
It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here). In Part I, we discussed general First-In-Human (FIH) clinical trials, and...
Blog
What Does it Take? | First in Human Clinical Trials
Does the CRO you’re working with have what it takes to successfully conduct First-in-Human (FIH) clinical research? What are FIH trials?It’s important to define what...
Blog
What Really Happens in a Clinical Lab – Part 2
Last week we talked about our awesome lab staff who are responsible for sample collection and processing during a clinical trial. This week, we’re highlighting our expert bioanalytical scien...
Blog
Volunteers Are Heroes
Recruiting volunteers for a clinical trial is vital to its success, but once volunteers are in house it’s paramount to retain them through the length of the study. This could be one...
Blog
FDA Issues Labeling Change for IR Opioid Medications
On March 22, 2016, the FDA announced that a labeling change will be required class-wide for immediate...